Citi expects Celsius to benefit from accelerating sales in 2025, helped by both its core Celsius brand and the recently acquired Alani Nu, which is expanding distribution and product innovation. The ...

Veea has engaged an unnamed placement agent to arrange the sale of securities on a "reasonable best efforts" basis. The company noted that there is no established public trading market for the ...

The bioengineered tissue product was sold to a state-of-the-art medical complex on a major U.S. military base that serves approximately 200,000 active-duty personnel, retirees, and their families.

Investing.com -- Ikena Oncology Inc (NASDAQ: IKNA) stock rose 4.8% following the announcement of Kristin Yarema, Ph.D. as the Chief Executive Officer of ImageneBio, the company to be formed after ...

Investing.com -- Castle Biosciences Inc (NASDAQ: CSTL) stock surged 7.8% after the company announced that its DecisionDx-Melanoma test received Breakthrough Device designation from the U.S. Food and ...

In the completed Phase 1/2 EXPLORE44 trial, del-zota demonstrated statistically significant increases in exon skipping, substantial increases in dystrophin production, and a significant reduction in ...

Investing.com -- IonQ (NYSE: IONQ) stock rose 1.3% after the quantum computing firm announced a strategic collaboration with Australian research and development company Emergence Quantum to advance ...

Investing.com -- Jefferies has initiated coverage on Galaxy Digital (TSX: GLXY) with a Buy rating and a $35 price target given a stable, long-term cash flows from its AI data center operations and a ...